Orexo AB
Records under this name other than the patents Orexo AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,658,198 | Non-abusable pharmaceutical composition comprising opioids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,980,305 | Non-Abusable Pharmaceutical Composition Comprising Opioids Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,470,361 | Non-abusable pharmaceutical composition comprising opioids Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,622,972 | Abuse resistant formula Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,921,405 | New Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,486,527 | Composition for sustained drug delivery comprising geopolymeric binder Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,759,537 | 3H-IMIDAZO [4, 5 -C] Pyridine- 6 -Carboxamides as Anti-Inflammatory Agents Formerly held In force · High confidence | In force | High confidence | |
| US 10,251,834 | Transdermal drug administration device Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,940,330 | New Abuse-Resistant Pharmaceutical Composition for the Treatment of Opioid Dependence Formerly held In force · High confidence | In force | High confidence | |
| US 9,259,421 | Abuse-Resistant Pharmaceutical Composition for the Treatment of Opioid Dependence Formerly held In force · High confidence | In force | High confidence |